Literature DB >> 21263230

Piezoelectric permeabilization of mammalian dermal tissue for in vivo DNA delivery leads to enhanced protein expression and increased immunogenicity.

Kate E Broderick1, Thomas Kardos, Jay R McCoy, Michael P Fons, Stephen Kemmerrer, Niranjan Y Sardesai.   

Abstract

Electropermeabilization of mammalian cells is a technique that has been used for the delivery of therapeutics, such as DNA plasmids or DNA vaccines. Typically, delivery via electropermeabilization occurs through injection of the substance into the tissue of interest followed by the insertion of electrodes at the site and the application of brief electrical pulses. Here we detail a novel and innovative contactless electropermeabilization method to deliver DNA plasmids to dermal tissue in vivo. This process has the advantage of eliminating the insertion of additional needles that serve as electrodes to facilitate the application of electric pulses in conventional electroporation processes. Plasmid encoding GFP was injected into guinea pig skin and pulsed with the novel contactless electropermeabilization method. Three days following treatment, robust GFP expression was observed on the skin of pulsed animals. Strong humoral immune responses were also achieved when a DNA vaccine expressing the influenza antigen NP was delivered and pulsed using the novel device in comparison to naked injection alone. This delivery method has the advantage of being contactless and suggests that gene transfer via this mode warrants further development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21263230     DOI: 10.4161/hv.7.0.14559

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  8 in total

1.  Non-contact helium-based plasma for delivery of DNA vaccines. Enhancement of humoral and cellular immune responses.

Authors:  Richard J Connolly; Taryn Chapman; Andrew M Hoff; Michele A Kutzler; Mark J Jaroszeski; Kenneth E Ugen
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

2.  Contactless magneto-permeabilization for intracellular plasmid DNA delivery in-vivo.

Authors:  Thomas J Kardos; Dietmar P Rabussay
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

Review 3.  Electroporation delivery of DNA vaccines: prospects for success.

Authors:  Niranjan Y Sardesai; David B Weiner
Journal:  Curr Opin Immunol       Date:  2011-04-27       Impact factor: 7.486

4.  Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination.

Authors:  P Fagone; D J Shedlock; H Bao; O U Kawalekar; J Yan; D Gupta; M P Morrow; A Patel; G P Kobinger; K Muthumani; D B Weiner
Journal:  Gene Ther       Date:  2011-05-05       Impact factor: 5.250

5.  Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.

Authors:  Feng Lin; Xuefei Shen; Gleb Kichaev; Janess M Mendoza; Maria Yang; Philip Armendi; Jian Yan; Gary P Kobinger; Alexander Bello; Amir S Khan; Kate E Broderick; Niranjan Y Sardesai
Journal:  Hum Gene Ther Methods       Date:  2012-07-13       Impact factor: 2.396

6.  ElectroPen: An ultra-low-cost, electricity-free, portable electroporator.

Authors:  Gaurav Byagathvalli; Soham Sinha; Yan Zhang; Mark P Styczynski; Janet Standeven; M Saad Bhamla
Journal:  PLoS Biol       Date:  2020-01-10       Impact factor: 8.029

7.  Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation.

Authors:  Kate E Broderick; Amy Chan; Feng Lin; Xuefei Shen; Gleb Kichaev; Amir S Khan; Justin Aubin; Tracy S Zimmermann; Niranjan Y Sardesai
Journal:  Mol Ther Nucleic Acids       Date:  2012-02-14       Impact factor: 10.183

8.  Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation.

Authors:  Janess M Mendoza; Dinah H Amante; Gleb Kichaev; Christine L Knott; William B Kiosses; Trevor R F Smith; Niranjan Y Sardesai; Kate E Broderick
Journal:  Vaccines (Basel)       Date:  2013-08-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.